These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34027801)

  • 1. Long term follow-up of visual acuity and incidence of subretinal neovascularization in Mactel Type 2 in 82 Eyes.
    Marsonia K; Kiran Chandra K; Ali MH; Chhablani J; Narayanan R
    Semin Ophthalmol; 2022 Feb; 37(2):136-141. PubMed ID: 34027801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macular Telangiectasia Type 2: Visual Acuity, Disease End Stage, and the MacTel Area: MacTel Project Report Number 8.
    Heeren TFC; Chew EY; Clemons T; Fruttiger M; Balaskas K; Schwartz R; Egan CA; Charbel Issa P;
    Ophthalmology; 2020 Nov; 127(11):1539-1548. PubMed ID: 32586743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-Term Results of Full Macular Translocation for Choroidal Neovascularization in Age-Related Macular Degeneration.
    van Romunde SH; Polito A; Bertazzi L; Guerriero M; Pertile G
    Ophthalmology; 2015 Jul; 122(7):1366-74. PubMed ID: 25881514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of choroidal neovascularization using intravitreal bevacizumab.
    Pedersen R; Soliman W; Lund-Andersen H; Larsen M
    Acta Ophthalmol Scand; 2007 Aug; 85(5):526-33. PubMed ID: 17511757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CORRELATION OF CLINICAL AND STRUCTURAL PROGRESSION WITH VISUAL ACUITY LOSS IN MACULAR TELANGIECTASIA TYPE 2: MacTel Project Report No. 6-The MacTel Research Group.
    Peto T; Heeren TFC; Clemons TE; Sallo FB; Leung I; Chew EY; Bird AC
    Retina; 2018 Jan; 38 Suppl 1(Suppl 1):S8-S13. PubMed ID: 28505012
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Choroidal Thickness in Patients with Proliferative and Non-Proliferative Macular Telangiectasia Using Enhanced Depth Imaging Optical Coherence Tomography.
    Demir G; Cakir I; Alkin Z; Demircan A; Tulu B; Fazıl K
    Curr Eye Res; 2020 Apr; 45(4):504-508. PubMed ID: 31899966
    [No Abstract]   [Full Text] [Related]  

  • 7. Etiology, Treatment Patterns, and Outcomes for Choroidal Neovascularization in the Pediatric Population: An Intelligent Research in Sight (IRIS®) Registry Study.
    Finn AP; Fujino D; Lum F; Rao P
    Ophthalmol Retina; 2022 Feb; 6(2):130-138. PubMed ID: 34091079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FACTORS INFLUENCING VISUAL ACUITY IN PATIENTS RECEIVING ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR FOR MYOPIC CHOROIDAL NEOVASCULARIZATION.
    Iacono P; Battaglia Parodi M; Selvi F; Parravano MC; Chiaravalloti A; Varano M; Bandello F
    Retina; 2017 Oct; 37(10):1931-1941. PubMed ID: 28033235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Visual Outcomes and Causes of Vision Loss in Chronic Central Serous Chorioretinopathy.
    Mrejen S; Balaratnasingam C; Kaden TR; Bottini A; Dansingani K; Bhavsar KV; Yannuzzi NA; Patel S; Chen KC; Yu S; Stoffels G; Spaide RF; Freund KB; Yannuzzi LA
    Ophthalmology; 2019 Apr; 126(4):576-588. PubMed ID: 30659849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes by Baseline Choroidal Neovascularization Features in Age-Related Macular Degeneration: A Post Hoc Analysis of the VIEW Studies.
    Steinle NC; Du W; Gibson A; Saroj N
    Ophthalmol Retina; 2021 Feb; 5(2):141-150. PubMed ID: 32652314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANTIANGIOGENICS IN CHOROIDAL NEOVASCULARIZATION ASSOCIATED WITH LASER IN CENTRAL SEROUS CHORIORETINOPATHY.
    Chhablani J; Pichi F; Silva R; Casella AM; Murthy H; Banker A; Nowilaty SR; Carrai P; Nucci P; Arevalo JF;
    Retina; 2016 May; 36(5):901-8. PubMed ID: 27115855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Punctate Inner Choroidopathy and Choroidal Neovascularization in Korean Patients.
    Lee JH; Lee SC; Park SJ; Lee CS
    Ocul Immunol Inflamm; 2020; 28(1):14-19. PubMed ID: 30547702
    [No Abstract]   [Full Text] [Related]  

  • 13. One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation.
    Singh SR; Fung AT; Fraser-Bell S; Lupidi M; Mohan S; Gabrielle PH; Zur D; Iglicki M; M López-Corell P; Gallego-Pinazo R; Farinha C; Lima LH; Mansour AM; Casella AM; Wu L; Silva R; Uwaydat SH; Govindahari V; Arevalo JF; Chhablani J
    Br J Ophthalmol; 2020 May; 104(5):678-683. PubMed ID: 31401554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal ziv-aflibercept for the treatment of choroidal neovascularisation associated with conditions other than age-related macular degeneration.
    Braimah IZ; Stewart M; Videkar C; Dedhia CJ; Chhablani J;
    Br J Ophthalmol; 2017 Sep; 101(9):1201-1205. PubMed ID: 28119292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence or absence of choroidal hyper-transmission by SD-OCT imaging distinguishes inflammatory from neovascular lesions in myopic eyes.
    Shi X; Cai Y; Luo X; Liang S; Rosenfeld PJ; Li X
    Graefes Arch Clin Exp Ophthalmol; 2020 Apr; 258(4):751-758. PubMed ID: 31907643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative factors influencing visual outcome following surgical excision of subfoveal choroidal.
    Shimada H; Fujita K; Matsumoto Y; Mori R; Yuzuwa M
    Eur J Ophthalmol; 2006; 16(2):287-94. PubMed ID: 16703548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features of macular telangiectasia type 2 and comparison of staging system in Taiwanese patients.
    Chen YY; Chen YL; Wu JS; Chen SN
    Taiwan J Ophthalmol; 2023; 13(3):346-352. PubMed ID: 38089515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of choroidal neovascularization secondary to angioid streaks.
    Mori H; Yamada H; Takahashi K
    Graefes Arch Clin Exp Ophthalmol; 2020 Sep; 258(9):1863-1869. PubMed ID: 32472199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal bevacizumab for the management of choroidal neovascularization in age-related macular degeneration.
    Bashshur ZF; Bazarbachi A; Schakal A; Haddad ZA; El Haibi CP; Noureddin BN
    Am J Ophthalmol; 2006 Jul; 142(1):1-9. PubMed ID: 16815245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term variable outcome of myopic choroidal neovascularization treated with ranibizumab.
    Cohen SY; Nghiem-Buffet S; Grenet T; Dubois L; Ayrault S; Fajnkuchen F; Delahaye-Mazza C; Quentel G; Tadayoni R
    Jpn J Ophthalmol; 2015 Jan; 59(1):36-42. PubMed ID: 25416566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.